Booking Holdings (BKNG) — Q2 2026 Earnings Preview

Earnings Date: August 4, 2026 | Reporting Period: Q2 2026 (quarter ending June 30, 2026) | Prepared: August 3, 2026

1. Earnings Preview

Key Takeaway: The setup into BKNG’s Q2 print is constructive — consensus is a low bar given the ~3pt Middle East headwind baked into guidance, and the key question is whether the recovery trajectory in H2 is intact. The wildcard is whether the Middle East conflict impact moderated faster than expected in June, which would drive a beat on room nights.

The bar heading into Q2 is intentionally low: management guided room night growth of only +2% to +4% (vs. a normalized ~8% ex-Middle East), with approximately 3 percentage points of headwind from the conflict embedded in the guide. Guidance was set conservatively at the April 28 Q1 earnings call, assuming the direct and indirect Middle East impact would persist through end of June — a posture management has not formally revised since. Estimate trajectory has been remarkably stable since the Q1 print: consensus room nights sit at ~320M and revenue at ~$7.19B, essentially unchanged from the post-Q1 baseline, suggesting the Street is waiting for Q2 results to reset H2 expectations rather than pre-positioning. The stock is up ~11% since earnings (from $173.38 to $192.71), outperforming the S&P 500 (+6.5%) but lagging EXPE (+23%), indicating the market has partially priced in a recovery but BKNG has not fully re-rated — likely reflecting its greater Middle East exposure and more conservative H2 guidance. The key wildcard is the pace of Middle East recovery in May–June: if cancellations normalized faster than assumed — as suggested by Marriott and Hilton’s Q2 results, which both came in better than feared on Middle East metrics — BKNG could beat on room nights and, more importantly, raise H2 guidance, which would be the primary catalyst for a meaningful re-rating.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a low bar on room nights (2–4% guided vs. ~8% normalized), but the real test is whether management raises H2 guidance. Revenue and EBITDA are the secondary swing factors; both are tracking in line with the guidance midpoint.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual

Q2 2025 Actual

Q2 2026 Consensus

YoY Change

Q2 2026 Guidance

Consensus vs. Guidance

Total Revenue

$5,532M

$6,798M

$7,191M

+5.8%

+4% to +6%

In line with midpoint

Hotel Room Nights (M)

338M

309M

320M

+3.6%

+2% to +4%

In line with midpoint

Gross Bookings

$53,758M

$46,700M

$49,399M

+5.8%

+4% to +6%

In line with midpoint

Adj. EBITDA

$1,290M

$2,423M

$2,559M

+5.6%

+4% to +6%

In line with midpoint

Adj. EPS (Diluted)

$1.14

$2.22

$2.41

+8.6%

N/A

N/A

ADR ($)

$138.19

$132.87

$135.05

+1.6%

Slightly down YoY (ME impact)

Slightly below guidance

Take Rate (%)

10.29%

14.56%

14.55%

-0.01pp

N/A

N/A

Gross Bookings Growth (%)

+15.2%

+12.8%

+5.9%

-6.9pp YoY

+4% to +6%

In line

Source: Visible Alpha consensus and actuals. Q2 2026 guidance provided on April 28, 2026 Q1 earnings call. Guidance assumes ~3pts of Middle East headwind on room nights. Q1 2026 Actual figures are the most recently reported quarter (not the current reporting quarter).

Table 2 — Beat/Miss History (Last 8 Quarters)

Hotel Room Nights Sold

Quarter

Reported (M)

Consensus (M)

Surprise %

Result

Q2 2024

287

285

+0.8%

Beat

Q3 2024

299

291

+2.8%

Beat

Q4 2024

261

250

+4.4%

Beat

Q1 2025

319

318

+0.3%

In Line

Q2 2025

309

305

+1.3%

Beat

Q3 2025

323

316

+2.2%

Beat

Q4 2025

285

279

+2.2%

Beat

Q1 2026

338

341

-0.9%

Miss

Adj. EPS (Diluted — Operating)

Quarter

Reported ($)

Consensus ($)

Surprise %

Result

Q2 2024

$1.68

$1.51

+11.3%

Beat

Q3 2024

$3.36

$3.04

+10.5%

Beat

Q4 2024

$1.66

$1.47

+12.9%

Beat

Q1 2025

$0.99

$0.72

+37.5%

Beat

Q2 2025

$2.22

$2.00

+10.8%

Beat

Q3 2025

$3.99

$3.86

+3.4%

Beat

Q4 2025

$1.95

$1.93

+1.2%

Beat

Q1 2026

$1.14

$1.07

+6.5%

Beat

Pattern: BKNG has beaten Adj. EPS consensus in 7 of the last 8 quarters with an average surprise of ~12%. The Q1 2026 room night miss was entirely attributable to the Middle East conflict onset in late February; EPS still beat by +6.5%. Source: Visible Alpha.

3. Guidance & Commentary Evolution

Key Takeaway: Guidance was set conservatively at Q1 earnings (April 28, 2026) assuming Middle East impact through end of June; no formal revision since. The key question is whether the H2 recovery assumption holds — any upside commentary on the pace of Middle East normalization would be the primary catalyst.

Metric

Initial Guidance (Q1 Earnings, Apr 28, 2026)

Revised Guidance

Current Consensus

Note

Q2 Room Night Growth

+2% to +4%

+3.6% YoY (320M)

Assumes ~3pts ME headwind; normalized ~5–7%

Q2 Gross Bookings Growth

+4% to +6%

+5.9%

FX tailwind of ~2pts included

Q2 Revenue Growth

+4% to +6%

+5.8%

In line with guidance midpoint

Q2 Adj. EBITDA Growth

+4% to +6%

+5.6%

Margin expansion 0–25bps FY

FY 2026 Gross Bookings Growth

High single digits to low double digits

+9.6%

Assumes ME recovery in H2; FX tailwind ~2pts

FY 2026 Revenue Growth

High single digits

~9.6%

FX tailwind ~1.5pts

FY 2026 Adj. EPS Growth

Low to mid-teens

+10.2%

Long-term target 15%+; consensus at low end of range

FY 2026 Adj. EBITDA Margin

Expand 0–25bps YoY

~37.1%

Slight expansion from FY25; in line with guidance

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been essentially flat since the Q1 print — consensus has not moved materially, suggesting the market is waiting for Q2 results to reset H2 expectations. The gap between current consensus and guidance midpoint is minimal, leaving room for upside if the Middle East recovery is faster than assumed.

KPI / Period

Estimate ~May 3, 2026 (5 days post Q1 earnings)

Current Consensus

Estimate Delta (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Delta

Consensus vs. Guidance

Room Nights — Q2 2026

320M

320M

~0%

+2% to +4%

Unchanged

In line with midpoint

Revenue — Q2 2026

$7,179M

$7,191M

+0.2%

+4% to +6%

Unchanged

In line with midpoint

Adj. EPS — Q2 2026

$2.40

$2.41

+0.4%

N/A

N/A

N/A

Revenue — FY 2026

$29,382M

$29,342M

-0.1%

High single digits

Unchanged

In line

Adj. EPS — FY 2026

$10.41

$10.42

+0.1%

Low to mid-teens growth

Unchanged

In line (low end of range)

Estimates have been remarkably stable since the Q1 print, with virtually no revision in either direction. This suggests the Street is treating the Middle East headwind as fully priced and is waiting for Q2 results to determine whether H2 recovery assumptions are credible. Any upside to room nights or a raise in H2 guidance would likely drive meaningful positive estimate revisions. Source: Visible Alpha.

5. Stock Performance

Key Takeaway: BKNG is up ~11% since Q1 earnings, outperforming SPY (+6.5%) but lagging EXPE (+23%), suggesting the market has partially priced in a recovery but BKNG has not fully re-rated. The underperformance vs. EXPE likely reflects BKNG’s greater Middle East exposure and more conservative H2 guidance.

BKNG vs. EXPE (Peer) vs. S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings (April 28, 2026). Source: Yahoo Finance.

Sector ETF note: No pure-play OTA ETF exists; EXPE (Expedia Group) is used as the closest direct OTA peer for comparison. Key observations:

6. Material News & Developments

Key Takeaway: The most important development since Q1 earnings is the emerging evidence from hotel peers (MAR, HLT) that Middle East travel disruption is moderating faster than feared, which is a positive read-through for BKNG’s H2 recovery assumption.

7. Insider Transaction Activity

Key Takeaway: All three transactions since Q1 earnings were pre-planned 10b5-1 sales — no discretionary selling or buying. The absence of open-market purchases is notable given the stock’s post-earnings selloff, but the 10b5-1 nature of all sales removes any negative signal.

Name

Title

Transaction Type

Shares

Transaction Date

Disclosed Date

Note

Peter J. Millones

EVP, General Counsel

10b5-1 Planned Sale

62,500

May 26, 2026

May 27, 2026

Pre-planned; routine executive liquidity

Vanessa Ames Wittman

Director

10b5-1 Planned Sale

1,125

July 28, 2026

July 29, 2026

Pre-planned; small size, no signal

Robert J. Mylod Jr.

Director

10b5-1 Planned Sale

5,000 (indirect)

July 29, 2026

July 30, 2026

Pre-planned; indirect via Annox Capital LLC

Note: All transactions are 10b5-1 pre-planned sales. No open-market purchases or discretionary sales were filed since Q1 earnings. The lack of insider buying during the post-earnings selloff (stock dropped to ~$154) is worth noting but is not unusual given the 10b5-1 plan structure. Source: SEC Form 4 filings.

8. Peer Commentaries — Read-Throughs for Q2 2026

Key Takeaway: Peer commentary from the last 60 days is broadly constructive for BKNG’s Q2 print — hotel RevPAR is recovering, airline demand is robust, and Middle East headwinds are moderating faster than feared. The key upside risk is whether BKNG’s European/Asian corridor exposure saw a faster-than-expected recovery in May–June.

Note: Only commentary about Q2 2026 performance or forward-looking statements made after BKNG’s Q1 earnings (April 28, 2026) is included. Prior-quarter earnings results commentary is excluded.

Hotel Peers

Marriott International (MAR) — Q2 2026 Earnings (August 3, 2026)

Hilton Worldwide (HLT) — Q2 2026 Earnings (July 28, 2026)

Marriott at Morgan Stanley Travel & Leisure Conference (June 1, 2026)

OTA Peers

Expedia Group (EXPE) — Q1 2026 Earnings (May 7, 2026) — Q2 Forward Guidance

Note: Q1 earnings commentary included here only for the Q2 2026 forward-looking guidance and April trend data provided on the call.

Airbnb (ABNB) — Q1 2026 Earnings (May 7, 2026) — Q2 Forward Guidance

Note: Q1 earnings commentary included here only for the Q2 2026 forward-looking guidance provided on the call.

Airlines

United Airlines (UAL) — Q2 2026 Earnings (July 16, 2026)

Delta Air Lines (DAL) — Q2 2026 Earnings (July 10, 2026)